2013 Advanced Therapies Summit
March 13-14, 2013 | Barcelona, Spain
Presented by the Alliance for Advanced Therapies
In Partnership with the Alliance for Regenerative Medicine
Register now to join the industry’s top leaders from Europe, the U.S. and Asia at the exclusive 2013 Advanced Therapies Summit!
Immediately following BIO-Europe Spring, on March 14th in Barcelona, the Alliance for Advanced Therapies, ARM’s European sister organization, will host the third edition of its successful summit. This year’s meeting will be focused on the innovation interests driving companies, academic institutes and other organizations involved in cell therapy, regenerative medicine, gene therapy and other potentially life-saving advanced therapeutics. This one-day program aims to facilitate meaningful dialogue and communication within the sector, while showcasing the industry to relevant stakeholders, including governments and investors.
Register today to join participants from top companies in the sector including Boehringer Ingelheim, Forbion, Kempen & Co, MHRA, PharmaCell, Pfizer, Promethera, ReNeuron, Shire and many others.
AAT / ARM Member Discount
AAT and ARM members receive a $200 euros discount for this event. Choose ‘ARM member’ when registering online.
Wednesday, March 13 | 7:30pm
Thursday, March 14 | 8:00am – 5:30pm
Advanced Therapies Summit
For the full event agenda and a complete list of speakers – click here
2013 Program Participants Include:
Alliance for Advanced Therapies
Alliance for Regenerative Medicine
Cell Therapy Catapult
Consulting on Advanced Biologicals
Janssen Pharmaceuticals, a Johnson & Johnson company
Kempen & Co
Medicines and Healthcare Products Regulatory Agency (U.K.)
ReNeuron Scalable Life Sciences
The Till Group
TiGenix Voisin Consulting
Contact Alliance for Advanced Therapies
Tel.: +31 79 362 29 50
Fax.: +31 79 360 03 06
For more information, please visit www.advancedtherapiessummit.eu
About the Advanced Therapies Summit
The Advanced Therapy Summit is an an annual, intimate discussion style event hosted by ARM’s European sister organization, The Alliance for Advanced Therapies. Each year, the event bringing together approximately 100-150 top executives from the regenerative medicine, cell therapy, immunotherapy, gene therapy, and pharmaceutical industry in US and Europe for high-level networking and discussion opportunities. The Summit addresses the field’s most pressing commercialization topics with discussion leaders from companies like Aldagen/Cytomedix, Athersys, J&J, Organovo, Pfizer, Reneuron, Shire and TiGenix.